The NIH Common Fund announces the FY2022 funding opportunity for the NIH Director’s New Innovator Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research. Any research topic relevant to the broad mission of NIH is welcome. NIH especially encourages applications from women and members of groups that are underrepresented in NIH-funded research.
Supports exceptionally creative early-career scientists proposing unusually innovative and high-impact projects. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied and formal sciences and topics that may involve basic, translational or clinical research.
- Early Stage Investigator only
- Single PI applications only
- No preliminary data required
- NEW CHANGES! $1.5 million in direct costs disbursed in two multi-year-funded segments of three years and two years
- PHS 2590 Non-Competing Continuation Progress Report (not a Multi-Year Funded Research Performance Progress Report [RPPR]) must be submitted in year three for funding the second award segment
- Detailed Budget pages must be completed according to the special instructions in the funding opportunity announcement
- Application deadline: Aug. 20, 2021
See the New Innovator Award website for more information, including FAQs, an application guide with sample applications, and past webinar (a new webinar will be forthcoming).
The High-Risk, High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices. The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs.